This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genmab A+s. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Thomas Valerius: Innovator in Cancer Treatment
Introduction
Thomas Valerius is a notable inventor based in Neuwittenbek, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic methods.
Latest Patents
Valerius holds a patent for "Methods and antibodies for treating cancer." This invention relates to novel methods for the treatment of tumors, comprising the administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention focuses on a method for inducing complement-mediated cell killing in the treatment of a tumor. This method involves the combined administration, to a human being in need thereof, of a first antibody and a second antibody.
Career Highlights
Valerius is currently associated with Genmab A/S, a leading biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer. His work at Genmab has positioned him as a key player in the advancement of cancer therapies.
Collaborations
Throughout his career, Valerius has collaborated with esteemed colleagues such as Jan Van De Winkel and Paul Parren. These collaborations have further enhanced his research and contributed to the development of innovative cancer treatments.
Conclusion
Thomas Valerius is a pioneering inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative methods and collaborations highlight the importance of research in the fight against cancer.